26.4.2008 EN Official Journal of the European Union L 114/99
COMMISSION DECISION
of 24 April 2008
on financial aid from the Community for the year 2008 for certain Community reference laboratories in the field of animal health and live animals
(notified under document number C(2008) 1570)
(Only the Spanish, Danish, German, English, French and Swedish texts are authentic)
(2008/332/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES
,
Having regard to the Treaty establishing the European Community,
Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 28(2) thereof,
Having regard to Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (2), and in particular Article 32(7) thereof,
Whereas:
(1) Pursuant to Article 28(1) of Decision 90/424/EEC Community reference laboratories in the field of animal health and live animals may be granted Community aid.
(2) Commission Regulation (EC) No 1754/2006 of 28 November 2006 laying down detailed rules for the granting of Community financial assistance to Community reference laboratories for feed and food and the animal health sector (3) provides that the financial assistance from the Community is to be granted if the approved work programmes are efficiently carried out and the beneficiaries supply all the necessary information within certain time limits.
(3) In accordance with Article 2 of Regulation (EC) No 1754/2006 the relationship between the Commission and Community reference laboratories is laid down in a partnership agreement which is supported by a multi-annual work programme.
(4) The Commission has assessed the work programmes and corresponding budget estimates submitted by the Community reference laboratories for the year 2008.
(5) Accordingly, Community financial assistance should be granted to the Community reference laboratories designated to carry out the functions and duties provided for in the following acts:
— Council Directive 2001/89/EC of 23 October 2001 on Community measures for the control of classical swine fever (4),
— Council Directive 92/66/EEC of 14 July 1992 introducing Community measures for the control of Newcastle disease (5),
— Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian influenza and repealing Directive 92/40/EEC (6),
— Council Directive 92/119/EEC of 17 December 1992 introducing general Community measures for the control of certain animals diseases and specific measures relating swine vesicular disease (7),
— Council Directive 2003/85/EC of 29 September 2003 on Community measures for the control of foot-and-mouth disease repealing Directive 85/511/EEC and Decisions 89/531/EEC and 91/665/EEC and amending Directive 92/46/EEC (8),
— Council Directive 93/53/EEC of 24 June 1993 introducing minimum Community measures for the control of certain fish diseases (9),
— Council Directive 95/70/EC of 22 December 1995 introducing minimum Community measures for the control of certain diseases affecting bivalve molluscs (10),
— Council Directive 92/35/EEC of 29 April 1992 laying down control rules and measures to combat African horse sickness (11),
— Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue (12),
— Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines (13),
— Regulation (EC) No 882/2004 for brucellosis,
— Council Directive 2002/60/EC of 27 June 2002 laying down specific provisions for the control of African swine fever and amending Directive 92/119/EEC as regards Teschen disease and African swine fever (14),
— Council Decision 96/463/EC of 23 July 1996 designating the reference body responsible for collaborating in rendering uniform the testing methods and the assessment of the results for pure-bred breeding animals of the bovine species (15).
(6) Financial assistance for the operation and organisation of workshops of Community reference laboratories should also be in conformity with the eligibility rules laid down in Regulation (EC) No 1754/2006.
(7) In accordance with Articles 3(2)(a) and 13 of Council Regulation (EC) No 1290/2005 of 21 June 2005 on the financing of the common agricultural policy (16) animal disease eradication and control programmes (veterinary measures) are to be financed from the European Agricultural Guarantee Fund. Nevertheless, in the present cases and in the absence of duly justified exceptional cases, expenditure relating to administrative and personnel costs incurred by Member States and beneficiaries of aid from the EAGF shall be excluded from financing by the Fund. For financial control purposes, Articles 9, 36 and 37 of that Regulation are to apply.
(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
For classical swine fever, the Community grants financial assistance to the Institut für Virologie der Tierärztlichen Hochschule Hannover, Hannover, Germany, to carry out the functions and duties set out in Annex IV to Directive 2001/89/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 241 000 for the period from 1 January to 31 December 2008, of which a maximum of EUR 18 000 shall be dedicated to the organisation of a technical workshop on classical swine fever diagnostic techniques.
For Newcastle disease, the Community grants financial assistance to the Veterinary Laboratories Agency (VLA), New Haw, Addlestone, United Kingdom, to carry out the functions and duties set out in Annex V to Directive 92/66/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 78 000 for the period from 1 January to 31 December 2008.
For avian influenza, the Community grants financial assistance to the Veterinary Laboratories Agency (VLA), New Haw, Addlestone, United Kingdom, to carry out the functions and duties set out in Annex VII to Directive 2005/94/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 414 000 for the period from 1 January to 31 December 2008.
For swine vesicular disease, the Community grants financial assistance to the AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, United Kingdom, to carry out the functions and duties set out in Annex III to Directive 92/119/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 135 000 for the period from 1 January to 31 December 2008.
For foot-and-mouth disease, the Community grants financial assistance to the Institute for Animal Health, Pirbright Laboratory, of the Biotechnology and Biological Sciences Research Council (BBSRC), Pirbright, United Kingdom, to carry out the functions and duties set out in Annex XVI to Directive 2003/85/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 312 000 for the period from 1 January to 31 December 2008.
For fish diseases, the Community grants financial assistance to the Statens Veterinære Serumlaboratorium, Aarhus, Denmark, to carry out the functions and duties set out in Annex C to Directive 93/53/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 212 000 for the period from 1 January to 31 December 2008.
For diseases of bivalve molluscs, the Community grants financial assistance to the IFREMER, La Tremblade, France, to carry out the functions and duties set out in Annex B to Directive 95/70/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 100 000 for the period from 1 January to 31 December 2008.
For African horse sickness, the Community grants financial assistance to the Laboratorio Central de Sanidad Animal de Algete, Algete (Madrid), Spain, to carry out the functions and duties set out in Annex III to Directive 92/35/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 70 000 for the period from 1 January to 31 December 2008.
For bluetongue, the Community grants financial assistance to the AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, United Kingdom, to carry out the functions and duties set out in Annex II(B) to Directive 2000/75/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 313 000 for the period from 1 January to 31 December 2008.
0
For rabies serology, the Community grants financial assistance to the AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, Nancy, France, to carry out the functions and duties set out in Annex II to Decision 2000/258/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 200 000 for the period from 1 January to 31 December 2008.
1
For brucellosis, the Community grants financial assistance to the AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses, Maisons-Alfort, France, to carry out the functions and duties set out in Article 32(2) of Regulation (EC) No 882/2004.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 246 000 for the period from 1 January to 31 December 2008, of which a maximum of EUR 26 000 shall be dedicated to the organisation of a technical workshop on brucellosis diagnostic techniques.
2
For African swine fever, the Community grants financial assistance to the Centro de Investigación en Sanidad Animal, Valdeolmos, Madrid, Spain, to carry out the functions and duties set out in Annex V to Directive 2002/60/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that research centre for the work programme and shall amount to a maximum of EUR 160 000 for the period from 1 January to 31 December 2008.
3
For collaborating in rendering uniform the testing methods and the assessment of the results for pure-bred breeding animals of the bovine species, the Community grants financial assistance to the INTERBULL Centre, Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden, to carry out the functions and duties set out in Annex II to Decision 96/463/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that centre for the work programme and shall amount to a maximum of EUR 90 000 for the period from 1 January to 31 December 2008.
4
This Decision is addressed to:
— Institut für Virologie der Tierärztlichen Hochschule, Bischofscholer Damm 15 D-3000, Hannover, Germany,
— Veterinary Laboratories Agency (VLA) Weybridge, New Haw, Addelstone, Surrey KT15 3NB United Kingdom,
— AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 ONF, United Kingdom,
— Statens Veterinære Serumlaboratorium, Hangovej 2, 8200-Åarhus, Denmark,
— Ifremer, B.P. 133 17390 La Tremblade, France,
— Laboratorio Central de Sanidad Animal de Algete, Ctra. De Algete km. 8, Valdeolmos, 281100, Algete (Madrid), Spain,
— AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, site de Nancy, Domaine de Pixérécourt, BP 9, F-54220 Malzéville, France,
— AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses, 23 avenue du Général de Gaulle F-94706 Maisons-Alfort, Cedex France,
— Centro de Investigación en Sanidad Animal, Ctra. De Algete a El Casar, Valdeolmos 28130, Madrid, Spain,
— Interbull Centre, Institutionen för husdjursgenetik, Sveriges Lantbruksuniversitet, Box 7023, S-750 07.